To explore the possibility that the reversal of gene expression could block breast tumor metastasis, we first tested monotreatment of PAC, DOC, or anti-PS antibody (αPS) and then combined these treatments to study the effects on both tumor growth and tumor metastasis in the lung. Here, PRB2 is linked to neoplasm.